Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02952183
What this trial is testing

Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors

Who this might be right for
Cervical CancerUterine CancerOvarian Cancer
Seoul National University Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797283
What this trial is testing

Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1

Who this might be right for
Ovarian Cancer
Incyte Corporation 590
Not applicableUnknownNCT04474951
What this trial is testing

Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies

Who this might be right for
Breast CancerGynecologic Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Early research (Phase 1)Study completedNCT00989651
What this trial is testing

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube CarcinosarcomaFallopian Tube Clear Cell Adenocarcinoma+35 more
National Cancer Institute (NCI) 431
Not applicableUnknownNCT00238342
What this trial is testing

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

Who this might be right for
Fallopian Tube CancerOvarian Cancer
Gynecologic Oncology Group 2,000
Testing effectiveness (Phase 2)Study completedNCT00477386
What this trial is testing

Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Indiana University 28
Not applicableStudy completedNCT06614062
What this trial is testing

Clinical Study of 18F-FAPI-RGD in Ovarian Cancer

Who this might be right for
Observational
Sichuan Provincial People's Hospital 30
Early research (Phase 1)Study completedNCT03508570
What this trial is testing

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

Who this might be right for
Malignant Peritoneal NeoplasmMalignant Retroperitoneal NeoplasmMetastatic Cervical Carcinoma+31 more
M.D. Anderson Cancer Center 26
Not applicableEnded earlyNCT03412630
What this trial is testing

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
ECOG-ACRIN Cancer Research Group 1
Testing effectiveness (Phase 2)Study completedNCT03318900
What this trial is testing

T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer

Who this might be right for
COL6A3 PositiveHLA-A*0201 Positive Cells PresentPRAME Positive+1 more
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00945139
What this trial is testing

Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)

Who this might be right for
Ovarian Cancer
New Mexico Cancer Research Alliance 46
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Testing effectiveness (Phase 2)Ended earlyNCT04493619
What this trial is testing

PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Who this might be right for
Gynecologic NeoplasmsEpithelial Ovarian Cancer
Opna Bio LLC 37
Not applicableLooking for participantsNCT06331130
What this trial is testing

Mesenteric Infiltration in Ovarian Cancer

Who this might be right for
Ovary Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 510
Testing effectiveness (Phase 2)Study completedNCT01121406
What this trial is testing

BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Boehringer Ingelheim 110
Not applicableActive Not RecruitingNCT07555639
What this trial is testing

An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity

Who this might be right for
Colon CancerBreast CancerOvarian Cancer+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 4,000
Not applicableLooking for participantsNCT07760012
What this trial is testing

68Ga-SorB PET/CT Imaging in Patients With Solid Tumors

Who this might be right for
Melanoma (Skin Cancer)Hepatocellular CarcinomaLung Cancer+3 more
Peking University Third Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00664781
What this trial is testing

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
Cancer Research UK 78
Testing effectiveness (Phase 2)Looking for participantsNCT06686030
What this trial is testing

Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer

Who this might be right for
Platinum-sensitive Ovarian Cancer
Akeso 150
Testing effectiveness (Phase 2)Study completedNCT00182767
What this trial is testing

Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 45
Next Page